These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 946714)

  • 41. Prediction of response to bromocriptine in acromegaly.
    Atkinson AB; Trimble ER; Hadden DR; Sheridan B
    Ulster Med J; 1978; 47(1):73-8. PubMed ID: 653899
    [No Abstract]   [Full Text] [Related]  

  • 42. Gel filtration studies of serum growth hormone in acromegaly following bromocriptine administration.
    Benker G; Sandmann K; Tharandt L; Hackenberg K; Reinwein D
    Horm Res; 1979; 11(3):151-60. PubMed ID: 488905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in plasma GH levels and clinical activity during bromocriptine therapy in acromegaly. The value of predictive tests.
    Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F
    Acta Endocrinol (Copenh); 1984 Jun; 106(2):175-83. PubMed ID: 6145276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bromocriptine treatment over 12 years in acromegaly: effect on glucose tolerance and insulin secretion.
    Rau H; Althoff PH; Schmidt K; Badenhoop K; Usadel KH
    Clin Investig; 1993 May; 71(5):372-8. PubMed ID: 8508007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Letter: Bromocriptine and growth hormone.
    Morgan L; Barrett A; Hobbs JR
    Lancet; 1976 Jan; 1(7952):195. PubMed ID: 54704
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effect of dopaminergic stimulation on growth hormone and prolactin in the treatment of acromegaly].
    Nedvídková J; Felt V
    Vnitr Lek; 1980 Oct; 26(10):988-93. PubMed ID: 7467150
    [No Abstract]   [Full Text] [Related]  

  • 47. Bromocriptine in the medical management of acromegaly.
    Besser GM; Wass JA; Thorner MO
    Adv Biochem Psychopharmacol; 1980; 23():191-8. PubMed ID: 6249090
    [No Abstract]   [Full Text] [Related]  

  • 48. Sleep-related growth hormone release following 2-bromo-alpha-ergocriptine treatment in acromegalic patients.
    Chihara K; Kato Y; Abe H; Furumoto M; Maeda K
    J Clin Endocrinol Metab; 1977 Jan; 44(1):78-84. PubMed ID: 576232
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term treatment of acromegaly with bromocriptine.
    Eskildsen PG; Svendsen PA; Vang L; Nerup J
    Acta Endocrinol (Copenh); 1978 Apr; 87(4):687-700. PubMed ID: 417539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Growth hormone, insulin, and prolactin secretion in anorexia nervosa and obesity during bromocriptine treatment.
    Harrower AD; Yap PL; Nairn IM; Walton HJ; Strong JA; Craig A
    Br Med J; 1977 Jul; 2(6080):156-9. PubMed ID: 577473
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S53-67. PubMed ID: 12211141
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effect of CB-154 on acromegaly].
    Kato Y; Iwasaki Y; Chihara K; Imura H
    Horumon To Rinsho; 1977 Dec; 25(12):1332-6. PubMed ID: 598038
    [No Abstract]   [Full Text] [Related]  

  • 53. Letter: Growth-hormone response to bromocriptine in parkinsonism.
    Shaw KM; Lees AJ; Hayes S; Ross EJ; Stern GM; Thompson BD
    Lancet; 1976 Jan; 1(7952):194. PubMed ID: 54702
    [No Abstract]   [Full Text] [Related]  

  • 54. Failure of bromocriptine to alter the qualitative characteristics of human growth hormone in acromegaly.
    Hizuka N; Hendricks CM; Roth J; Gorden P
    Metabolism; 1984 Jun; 33(6):582-4. PubMed ID: 6727657
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Determination of growth hormone response to thyreoliberin in the evaluation of lisuride therapy of acromegaly].
    Felt V; Nedvídková J
    Vnitr Lek; 1982 Aug; 28(8):756-61. PubMed ID: 6814061
    [No Abstract]   [Full Text] [Related]  

  • 56. Medical management of acromegaly with bromocriptine. Effects of continuous treatment for over three years.
    Besser GM; Wass JA
    Med J Aust; 1978 Nov; 2(3 Suppl):31-3. PubMed ID: 745579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Some alternatives of bromocriptin action of glucose tolerance in acromegalics (author's transl)].
    Dolecek R; Závada M
    Cas Lek Cesk; 1981; 120(51):1568-72. PubMed ID: 7034947
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of bromocriptine on plasma growth hormone and glucose tolerance in chronic renal failure.
    Kanis JA; Ledingham JG; Oliver DO; Walton RJ; Nairn IM
    Br Med J; 1976 Apr; 1(6014):879. PubMed ID: 1260390
    [No Abstract]   [Full Text] [Related]  

  • 59. [Acromegaly].
    Zapf J
    Schweiz Rundsch Med Prax; 1984 Mar; 73(10):293-8. PubMed ID: 6709989
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of hyperprolactinemia and acromegaly with lisuride].
    Berezin M; Elchalal U; Olchovsky D
    Harefuah; 1989 Jun; 116(12):634-7. PubMed ID: 2792946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.